Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BLRX Stock — BioLineRx Ltd
BioLineRx Ltd (BLRX)
Updated October 16, 2026.
BLRX is a Stock. Total return is -99.9% over the past 15.2 years, 762.7 points behind SPY at 662.8%.
BioLineRx Ltd. is a biopharmaceutical company developing therapeutics for oncology and rare diseases, with a pipeline including GLIX1 for glioblastoma, APHEXDA (motixafortide) in clinical trials for sickle cell disease and pancreatic cancer, and BL-5010 for non-surgical skin lesion removal. The company does not currently distribute dividends. BioLineRx appeals to investors seeking exposure to early-stage biopharmaceutical development rather than current income.
BLRX dividend yield and income
Price as of 2026-10-16.
The payment date is 07/15/2019.
BLRX performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.9% over the past 15.2 years, 762.7 points behind SPY at 662.8%. Over the past year its total return — price change plus distributions reinvested — is -47.4%. Its deepest 1-year drawdown was 47.4%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -18.9% | — |
| 3M | -32.5% | — |
| 6M | -15.9% | — |
| YTD | -27.4% | — |
| 1Y | -47.4% | — |
| 2Y CAGR | — | -67.30% |
| 3Y CAGR | — | -68.10% |
| 5Y CAGR | — | -56.00% |
| 10Y CAGR | — | -43.50% |
| Since inception (15.2 years) | -99.9% | -38.10% |
BLRX key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 07/27/2011
- Distribution frequency
- None
- Last close
- $2.01 (as of 2026-10-16)
- Market cap
- $10,006,214
- Average volume
- 12580.0
- Payment date
- 07/15/2019
- Beta
- 0.702
- Payout ratio
- 0.0%
- Forward P/E
- 93.4579
- EPS
- $0.00
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
BLRX risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 47.4%.
Who may consider BLRX — and who may not
It is a weaker fit for investors who need monthly cash flow (BLRX does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on BLRX
Frequently asked questions
Does BLRX pay monthly?
No. BLRX does not currently distribute.
When does BLRX pay a dividend?
BLRX does not currently distribute. The payment date is 07/15/2019.
How has BLRX performed?
Total return is -99.9% over the past 15.2 years, 762.7 points behind SPY at 662.8%. Over the past year its total return — price change plus distributions reinvested — is -47.4%. Its deepest 1-year drawdown was 47.4%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.